These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15975035)

  • 1. Modulating alloimmune responses with plasmapheresis and IVIG.
    Warren DS; Simpkins CE; Cooper M; Montgomery RA
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):215-22. PubMed ID: 15975035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
    Jordan SC; Peng A; Vo AA
    Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
    Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
    BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of plasmapheresis in ABO-incompatible renal transplantation.
    Tobian AA; Shirey RS; Montgomery RA; Ness PM; King KE
    Transfusion; 2008 Nov; 48(11):2453-60. PubMed ID: 18657072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
    Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature.
    Thukral S; Shinde N; Mukherjee K; Ray DS
    Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
    Wong NL; O'Connell P; Chapman JR; Nankivell B; Kable K; Webster AC; Wong G
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():22-4. PubMed ID: 25807854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report.
    Ray DS; Thukral S
    Am J Case Rep; 2017 Oct; 18():1073-1076. PubMed ID: 28983073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization in HLA-incompatible kidney recipients and survival.
    Montgomery RA; Lonze BE; King KE; Kraus ES; Kucirka LM; Locke JE; Warren DS; Simpkins CE; Dagher NN; Singer AL; Zachary AA; Segev DL
    N Engl J Med; 2011 Jul; 365(4):318-26. PubMed ID: 21793744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible matching significantly enhances transplant rates in kidney paired donation.
    Ferrari P; Hughes PD; Cohney SJ; Woodroffe C; Fidler S; D'Orsogna L
    Transplantation; 2013 Nov; 96(9):821-6. PubMed ID: 23860086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experience of ABO-incompatible kidney transplantation using plasmapheresis and anti-CD20 monoclonal antibody].
    Moon HW; Yun YM; Hur M; Park JH; Lee HW; Chang SH; Yun IJ
    Korean J Lab Med; 2009 Dec; 29(6):585-8. PubMed ID: 20046092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.
    Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA
    Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatch.
    Kayler LK; Colombe B; Farber JL; Lacava D; Dafoe DC; Burke JF; Francos GC; Ratner LE
    Clin Transplant; 2004 Dec; 18(6):737-42. PubMed ID: 15516254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
    Ray DS; Thukral S
    Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplantation across HLA and ABO antibody barriers.
    Becker LE; Süsal C; Morath C
    Curr Opin Organ Transplant; 2013 Aug; 18(4):445-54. PubMed ID: 23838650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.